UPDATE -- Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.
Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) through its wholly owned subsidiary Abba Medix Corp. (“Abba”) has initiated the process for its facility to become EU-GMP compliant by entering into a software licensing agreement (“SaaS Agreement”) with Cannabis OneFive, Inc. (“C15” www.cannabisonefive.com). The SaaS Agreement provides Abba with the use of C15’s Veeva Quality One unified quality management and document control solution.
C15’s leading software is based on its technology partner’s (Veeva Systems, Inc. www.industries.veeva.com) platforms configured, by C15, for the global cannabis industry. The C15 Veeva QualityOne cloud application is globally compliant with FDA 21 CFR Part 11; EU GMP Annex 11, and Cannabis Act regulations. This solution is a foundational quality management and document control system that has been adopted globally by over 650 of the top pharmaceutical and consumer packaged goods companies. The software digitally automates several processes related to supply chain management, including document control, compliance management, audit management, supplier quality management, and document training management while automating and meeting Health Canada license requirements.
This is a crucial move for Abba Medix as it moves to obtain European Medical Agency's Good Manufacturing Practices ("EU-GMP") Certification for their Pickering facility, as quality and document management software is a requirement for this certification.
Receiving the EU-GMP certification is a critical step for Abba Medix to be able to export our quality cannabis and seeds to the European Union,
said Canada House CEO Chris Churchill Smith,
Our Pickering facility occupies over 22,000 square feet and is expected to be able to produce between 2000 and 3000 kilograms per annum of dried flower at full capacity. This capacity, along with additional production capacity in Western Canada, allows us not only to meet the demands for premium cannabis within Canada but globally. The EU is of strategic importance to Canada House and we are delighted to have initiated the process to allow Abba products to be shipped to the EU by taking the requisite first steps to EU-GMP compliance.
For further information, please contact:
Boom Capital Markets
Steve Low
647-620-5101
steve@boomcapitalmarkets.com
Canada House Wellness Group Inc.
Chris Churchill-Smith, CEO
514-313-0102
chris.smith@canadahouse.ca
